TABLE I.
Genotype or genotype combinations of IL4RA (I50V), IL13 (R110Q), and CD14 (C159T) SNPs. | P-values | OR (95% CI) for genotype among diisocyanate exposed workers | ||
---|---|---|---|---|
Genotype or genotype combination main effect | Exposure main effect, HDI vs. MDI, TDI | Genotype or genotype combination by exposure interaction | ||
  A. All workers | ||||
IL4RA II | 0.810 | 0.0001 | 0.100 | 1.57 (0.74, 3.32)a |
IL4RA II and IL13 RR | 0.578 | 0.005 | 0.051 | 1.66 (0.66, 4.17)a |
IL4RA II and CD14 CT | 0.895 | 0.033 | 0.006 | 2.98 (1.25, 7.09)a |
IL4RA II and IL13RR and CD14 CT | 0.801 | 0.564 | 0.003 | 3.55 (1.19, 10.55)b |
  B. HDI workers only | ||||
IL4RA II | 0.292 | 1.51 (0.70, 3.28)a | ||
IL4RA II and IL13 RR | 0.340 | 1.58 (0.62, 4.06)a | ||
IL4RA II and CD14 CT | 0.015 | 3.08 (1.25, 7.60)a | ||
IL4RA II and IL13RR and CD14 CT | 0.019 | 3.86 (1.26, 11.98)c |
Note that genotypes are dichotomized so that IL4RA II compares the II genotype to the IV or VV genotypes; IL13 RR compares the RR genotype to the RQ or QQ genotypes; CD14 CT compares the CT genotype to the CC or TT genotype. Combinations of genotypes compare the indicated SNP combination to all other combinations. For example, IL4RA II and IL13 RR compares the combination of IL4RA (I50V) = II and IL-13 (R110Q) = RR to all other combinations of IL4RA (I50V) and IL-13 (R110Q).
Adjusted for smoking
Adjusted for smoking and ethnicity
Adjusted for smoking and gender